参麦联合苦碟子注射液治疗肺心病急性期的临床价值

The clinical value of Shenmai and Kudiezi injection in the treatment of acute pulmonary heart disease phase

目的探讨参麦联合苦碟子注射液对肺心病急性期的疗效。方法将102例患者随机分为对照组和治疗组,对照组48例采用常规治疗,治疗组54例于常规基础上加用参麦和苦碟子注射液,对两组血液流变学、动脉血气分析的疗效进行比较。结果治疗组血液流变学、动脉血气分析指标均有明显改善,与对照组相比差异有统计学意义(P<0.01)。治疗组总有效率93%,对照组总有效率73%,差异有统计学意义(P<0.05)。结论参麦联合苦碟子注射液治疗肺心病急性期疗效显著、安全、副作用小、具有重要的临床应用价值。

Objective Discussed clinical efficacy of Shenmai and Kudiezi injection in pulmonary heart disease acute phase. Methods The 102 cases were randomly divided into treatment group and control group. 48 cases in the control group used conventional treatment,group therapy in 54 patients with conventional treatment base- d on the use Shenmai and Kudiezi Injection.Two groups of hemorheology change and the effect of blood gas analysis were compared. Results The results of hemorheology and blood gas analysis in the treatment group significant improvement.and the control group were significantly different （P〈0.01）.In the treatment group 93% efficient, effecti-ve in the control group 73%,there was a significant difference（P〈0.05）. Conclusion Shen mai and Kudiezi injection treatment of acute pulmonary heart disease have a period of significant effect,the use of security, fewer side effects,has important clinical value.